Gene Symbol | Gene ID | Gene Info |
---|---|---|
MIXL1
|
ENSG00000185155.7 | Mix paired-like homeobox |
GSX1
|
ENSG00000169840.4 | GS homeobox 1 |
BSX
|
ENSG00000188909.4 | brain specific homeobox |
MEOX2
|
ENSG00000106511.5 | mesenchyme homeobox 2 |
LHX4
|
ENSG00000121454.4 | LIM homeobox 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_122848953_122849104 | BSX | 3400 | 0.242802 | -0.63 | 7.0e-02 | Click! |
chr11_122848668_122848819 | BSX | 3685 | 0.235037 | -0.51 | 1.6e-01 | Click! |
chr11_122855172_122855323 | BSX | 2819 | 0.263533 | -0.41 | 2.7e-01 | Click! |
chr11_122847424_122847575 | BSX | 4929 | 0.214504 | -0.35 | 3.5e-01 | Click! |
chr11_122854964_122855115 | BSX | 2611 | 0.275056 | -0.35 | 3.5e-01 | Click! |
chr13_28304503_28304654 | GSX1 | 62202 | 0.110972 | -0.81 | 8.6e-03 | Click! |
chr13_28364907_28365346 | GSX1 | 1654 | 0.420652 | -0.73 | 2.4e-02 | Click! |
chr13_28371306_28371457 | GSX1 | 4601 | 0.244213 | 0.67 | 5.0e-02 | Click! |
chr13_28303965_28304116 | GSX1 | 62740 | 0.109932 | -0.67 | 5.0e-02 | Click! |
chr13_28363537_28363907 | GSX1 | 3058 | 0.291171 | -0.62 | 7.4e-02 | Click! |
chr1_180197865_180198141 | LHX4 | 1418 | 0.460934 | -0.77 | 1.6e-02 | Click! |
chr1_180200314_180200720 | LHX4 | 1096 | 0.555051 | -0.57 | 1.1e-01 | Click! |
chr1_180201163_180201314 | LHX4 | 1817 | 0.385904 | -0.56 | 1.2e-01 | Click! |
chr1_180182570_180182974 | LHX4 | 16649 | 0.193292 | -0.42 | 2.6e-01 | Click! |
chr1_180199855_180200310 | LHX4 | 661 | 0.742049 | -0.37 | 3.2e-01 | Click! |
chr7_15841953_15842104 | MEOX2 | 115591 | 0.066451 | 0.94 | 2.1e-04 | Click! |
chr7_15791357_15791508 | MEOX2 | 64995 | 0.135795 | 0.88 | 1.6e-03 | Click! |
chr7_15960725_15960876 | MEOX2 | 234363 | 0.019976 | 0.88 | 1.8e-03 | Click! |
chr7_15794332_15794483 | MEOX2 | 67970 | 0.129806 | 0.84 | 4.4e-03 | Click! |
chr7_15931352_15931503 | MEOX2 | 204990 | 0.025568 | 0.81 | 8.5e-03 | Click! |
chr1_226412106_226412286 | MIXL1 | 877 | 0.602676 | -0.62 | 7.7e-02 | Click! |
chr1_226411700_226412091 | MIXL1 | 576 | 0.756495 | -0.55 | 1.3e-01 | Click! |
chr1_226411229_226411418 | MIXL1 | 4 | 0.978487 | -0.51 | 1.6e-01 | Click! |
chr1_226411026_226411177 | MIXL1 | 218 | 0.936605 | -0.10 | 8.0e-01 | Click! |
chr1_226412674_226412825 | MIXL1 | 1430 | 0.419240 | -0.02 | 9.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_178102702_178103151 | 3.20 |
RASAL2 |
RAS protein activator like 2 |
39650 |
0.22 |
chr11_126515519_126515813 | 3.12 |
RP11-115C10.1 |
|
7081 |
0.29 |
chr16_24742094_24743166 | 2.41 |
TNRC6A |
trinucleotide repeat containing 6A |
1596 |
0.5 |
chr17_60074998_60075962 | 2.31 |
ENSG00000242398 |
. |
7868 |
0.17 |
chr6_22026198_22026944 | 2.30 |
ENSG00000222515 |
. |
59202 |
0.17 |
chr22_26717807_26718076 | 2.27 |
SEZ6L |
seizure related 6 homolog (mouse)-like |
25740 |
0.18 |
chr1_31870163_31870721 | 2.11 |
SERINC2 |
serine incorporator 2 |
11970 |
0.15 |
chr9_14205951_14206102 | 1.97 |
NFIB |
nuclear factor I/B |
25229 |
0.27 |
chr1_210550900_210551051 | 1.96 |
ENSG00000200972 |
. |
3364 |
0.3 |
chr6_2103859_2104525 | 1.94 |
GMDS |
GDP-mannose 4,6-dehydratase |
72033 |
0.13 |
chr6_17906953_17907342 | 1.93 |
KIF13A |
kinesin family member 13A |
80547 |
0.1 |
chr10_93221945_93222246 | 1.90 |
HECTD2 |
HECT domain containing E3 ubiquitin protein ligase 2 |
198 |
0.97 |
chr10_74472843_74472994 | 1.80 |
MCU |
mitochondrial calcium uniporter |
856 |
0.58 |
chr18_72443447_72443598 | 1.78 |
ZNF407 |
zinc finger protein 407 |
100546 |
0.08 |
chr11_69048234_69048385 | 1.72 |
MYEOV |
myeloma overexpressed |
13296 |
0.27 |
chr11_111794482_111794633 | 1.69 |
CRYAB |
crystallin, alpha B |
111 |
0.93 |
chr13_77713051_77713202 | 1.69 |
MYCBP2 |
MYC binding protein 2, E3 ubiquitin protein ligase |
51477 |
0.13 |
chr1_227379724_227379875 | 1.68 |
RP11-1B20.1 |
|
13765 |
0.27 |
chr5_39072103_39073220 | 1.65 |
RICTOR |
RPTOR independent companion of MTOR, complex 2 |
1830 |
0.43 |
chr14_101308246_101309004 | 1.64 |
ENSG00000214548 |
. |
7020 |
0.04 |
chr7_46949633_46949784 | 1.63 |
AC011294.3 |
Uncharacterized protein |
212988 |
0.03 |
chr9_81321983_81322311 | 1.59 |
PSAT1 |
phosphoserine aminotransferase 1 |
410088 |
0.01 |
chr15_78594610_78594888 | 1.59 |
WDR61 |
WD repeat domain 61 |
2613 |
0.18 |
chr3_131121908_131122099 | 1.57 |
NUDT16 |
nudix (nucleoside diphosphate linked moiety X)-type motif 16 |
21374 |
0.15 |
chr5_139626504_139626769 | 1.57 |
CTB-131B5.2 |
|
46888 |
0.09 |
chr4_187545719_187545870 | 1.56 |
FAT1 |
FAT atypical cadherin 1 |
26616 |
0.2 |
chr13_110651559_110651710 | 1.56 |
ENSG00000201161 |
. |
84191 |
0.1 |
chr14_103480838_103481545 | 1.54 |
CDC42BPB |
CDC42 binding protein kinase beta (DMPK-like) |
42608 |
0.12 |
chr9_4137653_4137928 | 1.54 |
GLIS3 |
GLIS family zinc finger 3 |
7403 |
0.28 |
chr13_31774982_31775836 | 1.54 |
B3GALTL |
beta 1,3-galactosyltransferase-like |
1336 |
0.55 |
chr3_156478754_156479058 | 1.54 |
LEKR1 |
leucine, glutamate and lysine rich 1 |
65183 |
0.12 |
chr7_77496191_77496692 | 1.53 |
PHTF2 |
putative homeodomain transcription factor 2 |
26944 |
0.18 |
chr12_89339824_89340184 | 1.52 |
ENSG00000238302 |
. |
336058 |
0.01 |
chr18_32353571_32353898 | 1.51 |
RP11-138H11.1 |
|
6107 |
0.24 |
chr2_28027295_28027627 | 1.50 |
AC110084.1 |
|
18275 |
0.15 |
chr10_65024052_65024675 | 1.50 |
JMJD1C |
jumonji domain containing 1C |
4463 |
0.31 |
chr4_22515546_22516022 | 1.49 |
GPR125 |
G protein-coupled receptor 125 |
1836 |
0.52 |
chr14_74724538_74725207 | 1.48 |
VSX2 |
visual system homeobox 2 |
18697 |
0.14 |
chr4_20394815_20395096 | 1.47 |
SLIT2-IT1 |
SLIT2 intronic transcript 1 (non-protein coding) |
1143 |
0.66 |
chr13_24782132_24782457 | 1.47 |
SPATA13 |
spermatogenesis associated 13 |
43538 |
0.13 |
chr7_115872460_115873536 | 1.47 |
AC073130.3 |
|
6307 |
0.23 |
chr17_39218871_39219022 | 1.47 |
KRTAP2-3 |
keratin associated protein 2-3 |
2602 |
0.09 |
chr12_47497572_47497723 | 1.47 |
AMIGO2 |
adhesion molecule with Ig-like domain 2 |
23913 |
0.2 |
chr6_144587139_144587431 | 1.46 |
UTRN |
utrophin |
19552 |
0.24 |
chr5_14264414_14265476 | 1.46 |
TRIO |
trio Rho guanine nucleotide exchange factor |
26141 |
0.27 |
chr10_34451871_34452022 | 1.46 |
ENSG00000199200 |
. |
39056 |
0.23 |
chr6_56591218_56591369 | 1.46 |
DST |
dystonin |
59384 |
0.15 |
chr6_91072424_91072575 | 1.46 |
ENSG00000266760 |
. |
50038 |
0.15 |
chr4_48951442_48951593 | 1.46 |
ENSG00000252913 |
. |
16646 |
0.19 |
chr17_31210230_31210381 | 1.45 |
MYO1D |
myosin ID |
6110 |
0.19 |
chr7_17412244_17412395 | 1.44 |
ENSG00000199473 |
. |
631 |
0.81 |
chr7_137276747_137277035 | 1.44 |
PTN |
pleiotrophin |
248280 |
0.02 |
chr3_45521797_45522168 | 1.43 |
LARS2-AS1 |
LARS2 antisense RNA 1 |
29055 |
0.2 |
chr4_24553435_24554115 | 1.42 |
ENSG00000243005 |
. |
11309 |
0.21 |
chr11_96000343_96001397 | 1.41 |
ENSG00000266192 |
. |
73732 |
0.1 |
chr15_101668768_101669069 | 1.40 |
RP11-505E24.2 |
|
42647 |
0.16 |
chr5_158267521_158267691 | 1.39 |
CTD-2363C16.1 |
|
142408 |
0.05 |
chr18_456798_457125 | 1.39 |
RP11-720L2.2 |
|
32545 |
0.16 |
chr16_17931428_17931579 | 1.39 |
XYLT1 |
xylosyltransferase I |
366765 |
0.01 |
chr11_35643937_35644088 | 1.37 |
FJX1 |
four jointed box 1 (Drosophila) |
4277 |
0.27 |
chr12_120131477_120131628 | 1.37 |
RP1-127H14.3 |
Uncharacterized protein |
6021 |
0.18 |
chr3_111431650_111431801 | 1.37 |
PHLDB2 |
pleckstrin homology-like domain, family B, member 2 |
19619 |
0.18 |
chr1_87801300_87801913 | 1.36 |
LMO4 |
LIM domain only 4 |
4255 |
0.35 |
chr5_158397237_158397388 | 1.35 |
CTD-2363C16.1 |
|
12702 |
0.23 |
chr5_136899227_136899378 | 1.34 |
ENSG00000221612 |
. |
30159 |
0.2 |
chr16_72928505_72928656 | 1.34 |
ENSG00000251868 |
. |
72689 |
0.09 |
chr7_1443816_1444071 | 1.34 |
MICALL2 |
MICAL-like 2 |
55019 |
0.11 |
chrX_39832066_39832217 | 1.34 |
BCOR |
BCL6 corepressor |
90049 |
0.09 |
chr1_109938801_109939938 | 1.33 |
SORT1 |
sortilin 1 |
1204 |
0.42 |
chr4_40623166_40623743 | 1.33 |
RBM47 |
RNA binding motif protein 47 |
8427 |
0.27 |
chr15_67803044_67803195 | 1.33 |
C15orf61 |
chromosome 15 open reading frame 61 |
10287 |
0.21 |
chr19_39157057_39157758 | 1.33 |
ACTN4 |
actinin, alpha 4 |
19029 |
0.11 |
chr4_170150360_170150511 | 1.32 |
RP11-327O17.2 |
|
27490 |
0.21 |
chr10_99995580_99995731 | 1.32 |
RP11-34A14.3 |
|
16125 |
0.21 |
chr8_91783068_91783219 | 1.31 |
NECAB1 |
N-terminal EF-hand calcium binding protein 1 |
20635 |
0.19 |
chr11_27412970_27413121 | 1.31 |
CCDC34 |
coiled-coil domain containing 34 |
27630 |
0.19 |
chr1_200333826_200333977 | 1.31 |
ZNF281 |
zinc finger protein 281 |
45219 |
0.19 |
chr5_81460698_81461288 | 1.30 |
ENSG00000265684 |
. |
86747 |
0.08 |
chr9_130302299_130302610 | 1.30 |
FAM129B |
family with sequence similarity 129, member B |
28913 |
0.13 |
chr7_94035985_94036136 | 1.30 |
COL1A2 |
collagen, type I, alpha 2 |
12187 |
0.27 |
chr18_6730887_6731038 | 1.30 |
ARHGAP28 |
Rho GTPase activating protein 28 |
920 |
0.46 |
chr3_81777841_81778131 | 1.29 |
GBE1 |
glucan (1,4-alpha-), branching enzyme 1 |
14794 |
0.31 |
chr5_129440440_129440591 | 1.29 |
ENSG00000199455 |
. |
9587 |
0.3 |
chr3_98605745_98605896 | 1.29 |
DCBLD2 |
discoidin, CUB and LCCL domain containing 2 |
14195 |
0.17 |
chr7_33973779_33973930 | 1.29 |
BMPER |
BMP binding endothelial regulator |
28709 |
0.26 |
chr9_117877775_117877926 | 1.29 |
TNC |
tenascin C |
2628 |
0.36 |
chr9_94178983_94179134 | 1.29 |
NFIL3 |
nuclear factor, interleukin 3 regulated |
7086 |
0.3 |
chr4_152277546_152277697 | 1.29 |
FAM160A1 |
family with sequence similarity 160, member A1 |
52777 |
0.13 |
chr4_125861985_125862136 | 1.28 |
ANKRD50 |
ankyrin repeat domain 50 |
228173 |
0.02 |
chr15_45881879_45882313 | 1.28 |
BLOC1S6 |
biogenesis of lysosomal organelles complex-1, subunit 6, pallidin |
2073 |
0.2 |
chr4_169526190_169526341 | 1.28 |
PALLD |
palladin, cytoskeletal associated protein |
26501 |
0.19 |
chr20_11120768_11120919 | 1.27 |
C20orf187 |
chromosome 20 open reading frame 187 |
112032 |
0.07 |
chr11_78509149_78509300 | 1.26 |
TENM4 |
teneurin transmembrane protein 4 |
7232 |
0.27 |
chr5_158370461_158370612 | 1.26 |
CTD-2363C16.1 |
|
39478 |
0.18 |
chr13_60664906_60665057 | 1.26 |
DIAPH3-AS2 |
DIAPH3 antisense RNA 2 |
53851 |
0.12 |
chr1_85810423_85810574 | 1.26 |
DDAH1 |
dimethylarginine dimethylaminohydrolase 1 |
59682 |
0.09 |
chr4_85836939_85837233 | 1.25 |
ENSG00000252062 |
. |
29447 |
0.21 |
chr3_48075393_48075624 | 1.25 |
MAP4 |
microtubule-associated protein 4 |
17606 |
0.2 |
chr4_139819487_139819638 | 1.25 |
RP11-371F15.3 |
|
39573 |
0.17 |
chr3_141248480_141249204 | 1.24 |
RASA2-IT1 |
RASA2 intronic transcript 1 (non-protein coding) |
4867 |
0.27 |
chr8_143757168_143757384 | 1.24 |
PSCA |
prostate stem cell antigen |
4598 |
0.13 |
chr8_108235226_108235555 | 1.24 |
ENSG00000211995 |
. |
31336 |
0.25 |
chr2_161232105_161232912 | 1.23 |
ENSG00000252465 |
. |
20971 |
0.19 |
chr9_83650488_83650760 | 1.23 |
ENSG00000221581 |
. |
301380 |
0.01 |
chr22_24798801_24798960 | 1.23 |
ADORA2A |
adenosine A2a receptor |
20685 |
0.18 |
chr1_100110656_100110807 | 1.23 |
PALMD |
palmdelphin |
768 |
0.75 |
chr15_90950843_90951750 | 1.22 |
RP11-154B12.3 |
|
10183 |
0.16 |
chr1_25666704_25667414 | 1.22 |
ENSG00000252515 |
. |
403 |
0.75 |
chr7_116211652_116211947 | 1.21 |
AC006159.4 |
|
511 |
0.78 |
chr1_109912007_109912390 | 1.21 |
SORT1 |
sortilin 1 |
23781 |
0.14 |
chr1_43151129_43151715 | 1.21 |
YBX1 |
Y box binding protein 1 |
2764 |
0.23 |
chr3_152019223_152020002 | 1.21 |
MBNL1 |
muscleblind-like splicing regulator 1 |
1625 |
0.43 |
chr2_67877898_67878049 | 1.20 |
ETAA1 |
Ewing tumor-associated antigen 1 |
253522 |
0.02 |
chr2_153503173_153503324 | 1.20 |
FMNL2 |
formin-like 2 |
27156 |
0.22 |
chr20_45754256_45754424 | 1.20 |
ENSG00000264901 |
. |
41269 |
0.18 |
chr12_47515337_47515488 | 1.20 |
AMIGO2 |
adhesion molecule with Ig-like domain 2 |
41678 |
0.15 |
chr5_149679633_149679784 | 1.20 |
ARSI |
arylsulfatase family, member I |
2808 |
0.25 |
chr15_96102794_96102945 | 1.19 |
ENSG00000222076 |
. |
186164 |
0.03 |
chr10_127762727_127762878 | 1.19 |
ENSG00000222740 |
. |
71349 |
0.1 |
chr3_159600901_159601361 | 1.19 |
SCHIP1 |
schwannomin interacting protein 1 |
30403 |
0.17 |
chr4_186196562_186196713 | 1.19 |
SNX25 |
sorting nexin 25 |
65404 |
0.09 |
chr7_20071186_20071471 | 1.19 |
AC005062.2 |
|
28783 |
0.23 |
chr11_72020276_72020427 | 1.19 |
CLPB |
ClpB caseinolytic peptidase B homolog (E. coli) |
723 |
0.57 |
chr2_192352118_192352269 | 1.19 |
MYO1B |
myosin IB |
76402 |
0.11 |
chr8_38264429_38264741 | 1.19 |
RP11-350N15.6 |
|
1675 |
0.23 |
chr1_234755566_234755985 | 1.19 |
IRF2BP2 |
interferon regulatory factor 2 binding protein 2 |
10504 |
0.19 |
chr11_69084536_69085027 | 1.18 |
MYEOV |
myeloma overexpressed |
23156 |
0.25 |
chr2_208085162_208085313 | 1.18 |
AC007879.5 |
|
33739 |
0.16 |
chr6_135230784_135230935 | 1.18 |
ALDH8A1 |
aldehyde dehydrogenase 8 family, member A1 |
19440 |
0.21 |
chr3_149160630_149160781 | 1.18 |
TM4SF4 |
transmembrane 4 L six family member 4 |
31056 |
0.16 |
chr11_111848937_111849153 | 1.18 |
DIXDC1 |
DIX domain containing 1 |
1012 |
0.41 |
chr2_75819618_75819769 | 1.18 |
EVA1A |
eva-1 homolog A (C. elegans) |
22845 |
0.13 |
chr18_10213675_10214158 | 1.18 |
ENSG00000239031 |
. |
176081 |
0.03 |
chr5_66255925_66256427 | 1.17 |
MAST4 |
microtubule associated serine/threonine kinase family member 4 |
1360 |
0.56 |
chr8_25032357_25032508 | 1.17 |
ENSG00000241811 |
. |
6803 |
0.25 |
chr6_48743198_48743349 | 1.17 |
ENSG00000221175 |
. |
74287 |
0.13 |
chr9_91349114_91349265 | 1.16 |
ENSG00000265873 |
. |
11631 |
0.3 |
chr7_127410750_127410901 | 1.16 |
SND1 |
staphylococcal nuclease and tudor domain containing 1 |
117140 |
0.05 |
chr10_91186997_91187148 | 1.16 |
IFIT5 |
interferon-induced protein with tetratricopeptide repeats 5 |
12553 |
0.14 |
chr17_64419641_64419918 | 1.16 |
RP11-4F22.2 |
|
6807 |
0.26 |
chr17_71040137_71040288 | 1.16 |
SLC39A11 |
solute carrier family 39, member 11 |
45691 |
0.17 |
chr1_3230129_3230570 | 1.16 |
PRDM16 |
PR domain containing 16 |
69653 |
0.11 |
chr4_14728667_14728818 | 1.16 |
ENSG00000202449 |
. |
36408 |
0.24 |
chr9_90215657_90216062 | 1.16 |
DAPK1-IT1 |
DAPK1 intronic transcript 1 (non-protein coding) |
47490 |
0.16 |
chr12_69308314_69308612 | 1.15 |
ENSG00000252770 |
. |
2762 |
0.25 |
chrX_24073482_24074722 | 1.15 |
EIF2S3 |
eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa |
1014 |
0.57 |
chr5_158448429_158448934 | 1.15 |
CTD-2363C16.2 |
|
35867 |
0.17 |
chr11_74742246_74742397 | 1.15 |
NEU3 |
sialidase 3 (membrane sialidase) |
42331 |
0.11 |
chr15_58688767_58688918 | 1.15 |
LIPC |
lipase, hepatic |
13926 |
0.24 |
chr8_67472669_67472820 | 1.15 |
MYBL1 |
v-myb avian myeloblastosis viral oncogene homolog-like 1 |
52398 |
0.1 |
chr3_12550506_12550657 | 1.15 |
ENSG00000200114 |
. |
2131 |
0.22 |
chr2_36597145_36597296 | 1.15 |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
13606 |
0.29 |
chr3_114082824_114082975 | 1.15 |
ZBTB20-AS1 |
ZBTB20 antisense RNA 1 |
2665 |
0.28 |
chr12_14990014_14990290 | 1.14 |
RP11-233G1.4 |
|
3874 |
0.14 |
chr3_27208769_27208920 | 1.14 |
NEK10 |
NIMA-related kinase 10 |
49122 |
0.17 |
chr6_82477389_82477689 | 1.14 |
ENSG00000206886 |
. |
3798 |
0.25 |
chr1_10117217_10117368 | 1.14 |
UBE4B |
ubiquitination factor E4B |
23638 |
0.15 |
chr17_61352516_61352667 | 1.14 |
RP11-269G24.2 |
|
38291 |
0.15 |
chr3_197098695_197098846 | 1.14 |
ENSG00000238491 |
. |
32348 |
0.17 |
chr3_142719040_142719191 | 1.14 |
U2SURP |
U2 snRNP-associated SURP domain containing |
1251 |
0.46 |
chr21_22572082_22572504 | 1.14 |
AP001136.2 |
|
26857 |
0.24 |
chr1_196150065_196150216 | 1.14 |
ENSG00000265986 |
. |
401471 |
0.01 |
chr3_123476973_123477366 | 1.13 |
MYLK |
myosin light chain kinase |
35519 |
0.15 |
chr1_109740426_109740857 | 1.13 |
ENSG00000238310 |
. |
9829 |
0.15 |
chr2_64881941_64882849 | 1.13 |
SERTAD2 |
SERTA domain containing 2 |
1348 |
0.52 |
chr15_34205536_34205808 | 1.13 |
RP11-3D4.2 |
|
48646 |
0.13 |
chr1_86020329_86020665 | 1.13 |
DDAH1 |
dimethylarginine dimethylaminohydrolase 1 |
23436 |
0.17 |
chr10_101431369_101431801 | 1.13 |
ENTPD7 |
ectonucleoside triphosphate diphosphohydrolase 7 |
12322 |
0.15 |
chr2_224683617_224683768 | 1.13 |
AP1S3 |
adaptor-related protein complex 1, sigma 3 subunit |
18509 |
0.26 |
chr4_86683324_86683672 | 1.13 |
ARHGAP24 |
Rho GTPase activating protein 24 |
16361 |
0.24 |
chr17_65372251_65373170 | 1.12 |
PITPNC1 |
phosphatidylinositol transfer protein, cytoplasmic 1 |
865 |
0.53 |
chr12_105749863_105750120 | 1.12 |
C12orf75 |
chromosome 12 open reading frame 75 |
25345 |
0.17 |
chr4_1581689_1582176 | 1.12 |
FAM53A |
family with sequence similarity 53, member A |
75203 |
0.08 |
chr14_73928086_73928502 | 1.12 |
ENSG00000251393 |
. |
835 |
0.54 |
chr4_95749215_95749366 | 1.12 |
BMPR1B |
bone morphogenetic protein receptor, type IB |
70171 |
0.14 |
chr15_96817381_96817630 | 1.12 |
NR2F2-AS1 |
NR2F2 antisense RNA 1 |
1720 |
0.37 |
chr16_50059665_50060650 | 1.12 |
CNEP1R1 |
CTD nuclear envelope phosphatase 1 regulatory subunit 1 |
86 |
0.97 |
chr9_12860356_12860507 | 1.12 |
ENSG00000222658 |
. |
24889 |
0.2 |
chr8_142158040_142158331 | 1.11 |
DENND3 |
DENN/MADD domain containing 3 |
6883 |
0.21 |
chr3_47203435_47204414 | 1.11 |
SETD2 |
SET domain containing 2 |
1142 |
0.44 |
chr10_6763840_6763991 | 1.11 |
PRKCQ |
protein kinase C, theta |
141652 |
0.05 |
chr3_188067044_188067254 | 1.11 |
LPP |
LIM domain containing preferred translocation partner in lipoma |
109497 |
0.07 |
chr3_37114880_37115172 | 1.11 |
LRRFIP2 |
leucine rich repeat (in FLII) interacting protein 2 |
10215 |
0.17 |
chr13_98867933_98868084 | 1.11 |
ENSG00000263399 |
. |
7230 |
0.16 |
chr15_59641636_59642058 | 1.11 |
ENSG00000199512 |
. |
8231 |
0.13 |
chr8_12974192_12974343 | 1.11 |
DLC1 |
deleted in liver cancer 1 |
514 |
0.84 |
chr3_177463007_177463158 | 1.11 |
ENSG00000200288 |
. |
120885 |
0.06 |
chr1_65388564_65389365 | 1.11 |
JAK1 |
Janus kinase 1 |
43223 |
0.17 |
chr1_200763626_200763924 | 1.10 |
CAMSAP2 |
calmodulin regulated spectrin-associated protein family, member 2 |
54868 |
0.13 |
chr12_27751678_27751829 | 1.10 |
PPFIBP1 |
PTPRF interacting protein, binding protein 1 (liprin beta 1) |
528 |
0.82 |
chr2_153441109_153441260 | 1.10 |
FMNL2 |
formin-like 2 |
34908 |
0.22 |
chr3_124704068_124704219 | 1.10 |
HEG1 |
heart development protein with EGF-like domains 1 |
16721 |
0.2 |
chr2_100297232_100297383 | 1.10 |
AFF3 |
AF4/FMR2 family, member 3 |
102475 |
0.08 |
chr7_1462493_1462644 | 1.09 |
MICALL2 |
MICAL-like 2 |
36394 |
0.13 |
chr1_222065596_222065747 | 1.09 |
ENSG00000200033 |
. |
54892 |
0.17 |
chr4_170165351_170165677 | 1.09 |
SH3RF1 |
SH3 domain containing ring finger 1 |
25594 |
0.22 |
chr1_201645041_201645675 | 1.09 |
RP11-25B7.1 |
|
2086 |
0.26 |
chr7_115994446_115994930 | 1.09 |
ENSG00000216076 |
. |
8690 |
0.21 |
chr1_212841868_212842366 | 1.09 |
ENSG00000207491 |
. |
23489 |
0.13 |
chr8_118960048_118960199 | 1.08 |
EXT1 |
exostosin glycosyltransferase 1 |
162530 |
0.04 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.0 | GO:1900115 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.8 | 0.8 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.8 | 4.6 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.7 | 2.9 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.6 | 1.9 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.6 | 3.7 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.6 | 1.8 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.6 | 4.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.6 | 1.8 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.6 | 2.3 | GO:0070141 | response to UV-A(GO:0070141) |
0.6 | 2.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.6 | 1.7 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.5 | 2.1 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.5 | 2.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.5 | 1.5 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.5 | 1.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.5 | 3.4 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.5 | 1.0 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.4 | 1.8 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.4 | 1.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.4 | 1.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.4 | 0.4 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.4 | 2.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.4 | 1.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.4 | 0.7 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.4 | 1.1 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.4 | 1.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.4 | 1.4 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.4 | 0.4 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.4 | 1.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.4 | 1.1 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.3 | 1.4 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.3 | 1.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.3 | 1.0 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.3 | 0.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.3 | 2.5 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.3 | 0.6 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.3 | 0.9 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.3 | 0.3 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.3 | 0.9 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.3 | 0.9 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.3 | 1.8 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.3 | 1.2 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.3 | 2.1 | GO:0015871 | choline transport(GO:0015871) |
0.3 | 1.2 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.3 | 1.2 | GO:0060753 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.3 | 1.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 1.2 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.3 | 1.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.3 | 0.6 | GO:0061042 | vascular wound healing(GO:0061042) regulation of vascular wound healing(GO:0061043) |
0.3 | 0.6 | GO:0044413 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.3 | 0.8 | GO:0071436 | sodium ion export(GO:0071436) |
0.3 | 1.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.3 | 0.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 4.4 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.3 | 0.8 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.3 | 0.8 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.3 | 0.3 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.3 | 0.5 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.2 | 1.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 0.7 | GO:0008354 | germ cell migration(GO:0008354) |
0.2 | 0.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.7 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.7 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.2 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.2 | 0.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.5 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.2 | 0.7 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.2 | 2.3 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.2 | 0.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.2 | 0.4 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 0.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 2.2 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.2 | 0.2 | GO:0032353 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.2 | 0.4 | GO:0010193 | response to ozone(GO:0010193) |
0.2 | 0.8 | GO:0008218 | bioluminescence(GO:0008218) |
0.2 | 0.2 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.2 | 0.4 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.2 | 0.2 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.2 | 0.2 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.2 | 0.4 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.2 | 1.2 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 1.9 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.2 | 0.8 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 0.8 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.2 | 0.8 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 0.4 | GO:0060174 | limb bud formation(GO:0060174) |
0.2 | 0.6 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 0.6 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.2 | 3.2 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.2 | 0.6 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 0.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.9 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.2 | 0.2 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.2 | 0.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.2 | 0.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 2.2 | GO:0035329 | hippo signaling(GO:0035329) |
0.2 | 0.4 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.2 | 0.7 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.2 | 0.9 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 1.8 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.2 | 0.7 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.2 | 0.2 | GO:0003032 | detection of oxygen(GO:0003032) |
0.2 | 0.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.2 | 0.5 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.2 | 0.2 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.2 | 0.8 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.2 | 1.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.2 | 0.3 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
0.2 | 0.7 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.2 | 0.3 | GO:0070254 | mucus secretion(GO:0070254) |
0.2 | 0.8 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 0.5 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.2 | 4.1 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.2 | 0.3 | GO:0051280 | negative regulation of ion transmembrane transporter activity(GO:0032413) negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.2 | 0.7 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.2 | 0.6 | GO:0002076 | osteoblast development(GO:0002076) |
0.2 | 0.8 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
0.2 | 0.3 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.2 | 0.3 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 0.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 0.8 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.2 | 1.2 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.3 | GO:0046639 | negative regulation of alpha-beta T cell differentiation(GO:0046639) |
0.2 | 0.5 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.2 | 0.3 | GO:0032898 | neurotrophin production(GO:0032898) |
0.2 | 0.8 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.2 | 0.3 | GO:0060900 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) embryonic camera-type eye formation(GO:0060900) |
0.1 | 1.3 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.1 | 0.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.4 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.1 | 0.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 1.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.3 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.1 | 1.0 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.1 | 0.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.6 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 2.8 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.1 | 0.6 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 1.9 | GO:0030539 | male genitalia development(GO:0030539) |
0.1 | 0.4 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.3 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.1 | 0.4 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.1 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.1 | 0.3 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.1 | 0.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.5 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 1.7 | GO:0021988 | olfactory lobe development(GO:0021988) |
0.1 | 0.7 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.5 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 1.7 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.1 | 0.5 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.3 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.5 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 1.0 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.3 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.5 | GO:0070091 | glucagon secretion(GO:0070091) |
0.1 | 0.4 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.5 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 0.4 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.5 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.4 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.1 | 0.1 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 1.5 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.4 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.7 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.1 | 0.1 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 | 0.7 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.4 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.1 | 1.5 | GO:1901880 | negative regulation of protein depolymerization(GO:1901880) |
0.1 | 0.5 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 0.1 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.1 | 0.4 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.1 | 0.2 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.1 | 0.3 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.6 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 0.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.2 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 0.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.4 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 1.9 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.1 | 0.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.4 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.1 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.4 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.7 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.1 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.1 | 0.1 | GO:0072193 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.1 | 0.6 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 0.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.1 | GO:0033197 | response to vitamin E(GO:0033197) |
0.1 | 0.1 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.4 | GO:0051818 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.1 | 0.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.5 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
0.1 | 0.5 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.2 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.1 | 0.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.8 | GO:1902603 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.1 | 0.3 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.2 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.3 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.4 | GO:0015838 | amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.1 | 0.3 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 0.2 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.1 | 0.1 | GO:0007442 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.1 | 0.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.3 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.1 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.1 | 0.8 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.8 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.1 | 0.5 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.5 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 0.2 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.5 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.6 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
0.1 | 0.2 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.2 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.1 | 0.4 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.1 | 0.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.1 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 0.5 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.1 | 0.4 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.1 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.1 | 0.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 0.4 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.2 | GO:0061035 | regulation of cartilage development(GO:0061035) |
0.1 | 0.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.3 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 0.1 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 2.6 | GO:0060606 | neural tube closure(GO:0001843) tube closure(GO:0060606) |
0.1 | 0.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.2 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.3 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.8 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 1.2 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 0.2 | GO:0051955 | regulation of amino acid transport(GO:0051955) |
0.1 | 0.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.2 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.1 | 0.2 | GO:0036445 | neuronal stem cell division(GO:0036445) neuroblast division(GO:0055057) |
0.1 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.2 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.1 | 0.1 | GO:0051458 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.3 | GO:0090505 | wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
0.1 | 0.2 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
0.1 | 0.4 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.3 | GO:0031641 | regulation of myelination(GO:0031641) |
0.1 | 0.4 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.1 | 0.6 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.1 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.1 | 0.1 | GO:0060413 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.1 | 0.2 | GO:0060179 | male courtship behavior(GO:0008049) male mating behavior(GO:0060179) |
0.1 | 0.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.2 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.1 | 0.2 | GO:0048245 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.1 | 0.3 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.1 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.1 | 0.4 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.1 | 0.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.1 | 0.3 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.1 | 0.5 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.5 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.4 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.3 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 1.1 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 1.4 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.1 | 0.1 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 0.7 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
0.1 | 1.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 1.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.1 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.1 | 0.3 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 0.1 | GO:0010159 | specification of organ position(GO:0010159) |
0.1 | 0.2 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.4 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.4 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.3 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.6 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.2 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.1 | 0.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.3 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 1.0 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.6 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.1 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
0.1 | 0.1 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.1 | 0.1 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.1 | 0.1 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.1 | 0.3 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 1.0 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.1 | 0.1 | GO:0030728 | ovulation(GO:0030728) |
0.1 | 0.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.3 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.2 | GO:0051307 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.1 | 0.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 0.3 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.1 | 0.1 | GO:0003078 | obsolete regulation of natriuresis(GO:0003078) |
0.1 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.5 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.1 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 0.5 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.5 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.2 | GO:1901984 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.1 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.3 | GO:0001660 | fever generation(GO:0001660) |
0.1 | 0.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.5 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 1.0 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.2 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.1 | 0.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 0.1 | GO:1903020 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.6 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.1 | 0.4 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.1 | 0.9 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.2 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.1 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.2 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.1 | 0.2 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.1 | 0.2 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.1 | 0.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.2 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 0.4 | GO:0001841 | neural tube formation(GO:0001841) |
0.1 | 0.2 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
0.1 | 0.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 1.3 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 1.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.3 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.1 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.2 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.1 | 0.2 | GO:0060009 | Sertoli cell differentiation(GO:0060008) Sertoli cell development(GO:0060009) |
0.1 | 0.5 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.3 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.2 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.1 | 0.5 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
0.1 | 0.1 | GO:0032373 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.1 | 0.1 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.1 | 0.2 | GO:0006693 | prostaglandin metabolic process(GO:0006693) |
0.1 | 0.1 | GO:1902745 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
0.1 | 0.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.1 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.0 | 0.3 | GO:1902224 | ketone body metabolic process(GO:1902224) |
0.0 | 0.2 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.4 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) regulation of cellular response to insulin stimulus(GO:1900076) |
0.0 | 0.2 | GO:0030146 | obsolete diuresis(GO:0030146) |
0.0 | 0.0 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.1 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.0 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.3 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.0 | 0.4 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.0 | 0.1 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.0 | 0.8 | GO:1905037 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.0 | 0.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.1 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.0 | GO:0055006 | cardiac cell development(GO:0055006) cardiac muscle cell development(GO:0055013) |
0.0 | 0.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.7 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.0 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.2 | GO:0008595 | blastoderm segmentation(GO:0007350) tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.2 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.0 | GO:0030185 | nitric oxide transport(GO:0030185) |
0.0 | 0.5 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 1.3 | GO:0017157 | regulation of exocytosis(GO:0017157) |
0.0 | 0.2 | GO:0042559 | tetrahydrobiopterin biosynthetic process(GO:0006729) pteridine-containing compound biosynthetic process(GO:0042559) |
0.0 | 0.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.3 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.0 | 0.3 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.0 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.0 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.0 | 0.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.2 | GO:0051597 | response to methylmercury(GO:0051597) |
0.0 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.1 | GO:0009886 | post-embryonic morphogenesis(GO:0009886) |
0.0 | 0.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.1 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.2 | GO:0071453 | cellular response to decreased oxygen levels(GO:0036294) cellular response to oxygen levels(GO:0071453) cellular response to hypoxia(GO:0071456) |
0.0 | 0.1 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.1 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.1 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 0.0 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
0.0 | 0.6 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.0 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.0 | 0.3 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.0 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.0 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.2 | GO:0021983 | pituitary gland development(GO:0021983) |
0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.0 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.0 | 0.1 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.1 | GO:0042762 | regulation of sulfur metabolic process(GO:0042762) |
0.0 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.0 | GO:0060998 | regulation of dendritic spine development(GO:0060998) |
0.0 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.0 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.0 | 0.0 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.0 | 0.0 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.2 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.0 | 0.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.0 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.0 | 0.1 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.0 | 0.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.1 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.0 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.1 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.1 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.0 | 0.2 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.0 | 0.2 | GO:0006390 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.1 | GO:0060438 | trachea development(GO:0060438) |
0.0 | 0.3 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.1 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.0 | 0.0 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.0 | 0.1 | GO:0050795 | regulation of behavior(GO:0050795) |
0.0 | 0.1 | GO:0039703 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.1 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.0 | GO:0060911 | cardiac cell fate commitment(GO:0060911) |
0.0 | 0.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.0 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.0 | 0.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.0 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.0 | 0.2 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.1 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.9 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.0 | 3.5 | GO:0006936 | muscle contraction(GO:0006936) |
0.0 | 0.1 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.0 | 0.1 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.1 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.0 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.0 | 0.0 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 1.0 | GO:0030198 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.0 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.0 | GO:0072070 | loop of Henle development(GO:0072070) |
0.0 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.0 | 0.1 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.0 | 0.2 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.1 | GO:0003156 | regulation of organ formation(GO:0003156) |
0.0 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.1 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.0 | 0.4 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.2 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.1 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.0 | 0.1 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.0 | 0.0 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.1 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.0 | 0.3 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.0 | 0.1 | GO:0042490 | mechanoreceptor differentiation(GO:0042490) |
0.0 | 0.0 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.0 | 0.1 | GO:0032329 | serine transport(GO:0032329) |
0.0 | 0.0 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.0 | 0.1 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.0 | 0.2 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.2 | GO:0009251 | glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.0 | 0.1 | GO:0090026 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 2.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 1.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.4 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.0 | 0.1 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.0 | GO:0030239 | myofibril assembly(GO:0030239) |
0.0 | 0.1 | GO:0014075 | response to amine(GO:0014075) |
0.0 | 0.1 | GO:0070293 | renal absorption(GO:0070293) |
0.0 | 0.1 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.0 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.1 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.0 | 0.1 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.0 | 0.0 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.1 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.0 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.3 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.1 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.0 | 0.0 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.1 | GO:0071451 | removal of superoxide radicals(GO:0019430) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.0 | 0.2 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.0 | 0.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.0 | 0.1 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.0 | 0.1 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.0 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
0.0 | 0.0 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.0 | 0.0 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.0 | GO:0045073 | regulation of chemokine biosynthetic process(GO:0045073) |
0.0 | 0.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.0 | 0.3 | GO:0030282 | bone mineralization(GO:0030282) |
0.0 | 0.0 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.0 | 0.1 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.0 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) positive regulation of calcium ion import(GO:0090280) |
0.0 | 0.0 | GO:0006530 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.0 | 0.0 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.0 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.0 | 0.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.0 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.0 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.0 | 0.0 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 0.1 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.0 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.0 | 0.0 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.0 | 0.0 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.0 | 0.1 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.0 | 0.1 | GO:0034644 | cellular response to UV(GO:0034644) |
0.0 | 0.1 | GO:0048265 | response to pain(GO:0048265) |
0.0 | 0.2 | GO:0060348 | bone development(GO:0060348) |
0.0 | 0.0 | GO:1901655 | cellular response to ketone(GO:1901655) |
0.0 | 0.0 | GO:0071397 | cellular response to sterol(GO:0036315) cellular response to cholesterol(GO:0071397) |
0.0 | 0.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.0 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.0 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.0 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.1 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.0 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.0 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.0 | 0.0 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.1 | GO:0031214 | biomineral tissue development(GO:0031214) |
0.0 | 0.0 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.0 | 0.3 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.0 | 0.0 | GO:0016559 | peroxisome fission(GO:0016559) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 3.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.6 | 1.7 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.5 | 1.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.4 | 3.0 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.3 | 3.7 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 1.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 1.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.3 | 1.7 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.3 | 0.9 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.3 | 2.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 1.5 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 1.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 7.0 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 0.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 0.7 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.2 | 1.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 1.5 | GO:0002102 | podosome(GO:0002102) |
0.2 | 0.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 1.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 0.8 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.2 | 0.8 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.2 | 0.4 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 1.5 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 0.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 3.2 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.8 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.2 | 1.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 0.2 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.1 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.1 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.7 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.3 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 0.5 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.8 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 1.3 | GO:0043256 | laminin complex(GO:0043256) |
0.1 | 0.6 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 2.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.9 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.8 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.1 | 1.2 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.4 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 10.1 | GO:0030016 | myofibril(GO:0030016) |
0.1 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 1.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.3 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 0.4 | GO:0001520 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.1 | 3.9 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.3 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 20.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.1 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.1 | 0.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.5 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 1.6 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 1.9 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.1 | 3.4 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.3 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 1.9 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.2 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 0.6 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.9 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.8 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.8 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 3.3 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.4 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.1 | 0.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.5 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 4.1 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.1 | 0.3 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 1.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 1.0 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.0 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 1.2 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 0.3 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 2.5 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.9 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.2 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.0 | 0.1 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 1.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.2 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 3.5 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.2 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 1.4 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 1.0 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.0 | 0.1 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.1 | GO:0045277 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.3 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.2 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 2.5 | GO:0005912 | adherens junction(GO:0005912) |
0.0 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 1.2 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.1 | GO:0044309 | neuron spine(GO:0044309) |
0.0 | 0.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.7 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.3 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.0 | 0.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.1 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.4 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.5 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.0 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.3 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.1 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 7.8 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.3 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.3 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.6 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.3 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.4 | GO:0030658 | transport vesicle membrane(GO:0030658) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 3.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.1 | 4.2 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.9 | 2.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.8 | 2.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.7 | 2.7 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.6 | 1.9 | GO:0000987 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.5 | 1.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.5 | 2.6 | GO:0042805 | actinin binding(GO:0042805) |
0.5 | 3.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.4 | 4.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 4.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.4 | 1.5 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.3 | 1.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 1.6 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.3 | 1.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 1.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 1.3 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.3 | 2.2 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.3 | 0.9 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.3 | 0.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 0.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 1.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 0.9 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 1.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.3 | 0.8 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.3 | 3.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 1.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.3 | 1.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 0.8 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 1.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.3 | 1.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.3 | 0.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.3 | 0.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 0.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 0.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 1.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.2 | 1.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 0.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 0.7 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 0.7 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.2 | 0.7 | GO:0048185 | activin binding(GO:0048185) |
0.2 | 0.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 0.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 0.6 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.2 | 1.3 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.2 | 0.4 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.2 | 1.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 0.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.2 | 0.4 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.2 | 0.8 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 0.8 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 1.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.6 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 0.9 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.2 | 0.7 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 1.7 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.2 | 0.5 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.2 | 0.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.2 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.2 | 0.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 3.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 2.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 1.6 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.5 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.2 | 1.0 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.2 | 0.5 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.2 | 0.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.2 | 0.5 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.2 | 0.7 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 0.5 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.2 | 0.2 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.2 | 1.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 1.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 0.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 2.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 1.0 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 0.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.4 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 0.6 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.7 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 2.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 2.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.5 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.7 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 1.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.9 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.5 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.5 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.7 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.1 | 0.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 1.8 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.4 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 0.3 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 3.5 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 1.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.2 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 1.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.2 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.1 | 1.1 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.2 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 1.1 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.1 | 1.1 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 0.3 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 1.0 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.5 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.3 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.6 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.4 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 0.6 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 1.0 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.1 | 0.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.4 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.3 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.3 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.1 | 0.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.3 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.1 | 0.3 | GO:0004803 | transposase activity(GO:0004803) |
0.1 | 0.7 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.7 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 0.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.5 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.3 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 0.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.2 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.2 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.1 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.1 | 0.6 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 3.4 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 4.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.7 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.6 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.2 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.5 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.2 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.4 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 0.8 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.2 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 1.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.3 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 0.5 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 1.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.5 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.2 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 0.9 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 1.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.1 | 0.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.5 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.1 | 0.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.1 | 0.3 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.4 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.8 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.7 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.4 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.5 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.2 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
0.0 | 0.4 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.0 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0045569 | TRAIL binding(GO:0045569) |
0.0 | 0.2 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.0 | 0.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.4 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.3 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.5 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.3 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.2 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.2 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.1 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 1.9 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 1.4 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0034648 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.1 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 0.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.2 | GO:0030547 | receptor inhibitor activity(GO:0030547) receptor antagonist activity(GO:0048019) |
0.0 | 0.0 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.2 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.4 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.1 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.0 | 0.1 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.0 | 0.1 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.0 | 0.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 3.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.0 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.1 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.2 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.0 | 0.4 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.0 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 1.1 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.0 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.0 | 0.5 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.1 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 0.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.0 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.1 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.4 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.0 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.0 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.0 | 0.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.3 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.0 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.1 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.1 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 3.9 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.1 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.0 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 0.2 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.1 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 1.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.1 | GO:0015250 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.4 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.0 | 0.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.1 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) bisphosphoglycerate phosphatase activity(GO:0034416) |
0.0 | 0.7 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.1 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.0 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 1.2 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.0 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.0 | 0.2 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.1 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.0 | 0.0 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.1 | GO:0019825 | oxygen binding(GO:0019825) |
0.0 | 2.8 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.0 | 0.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.0 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.0 | GO:0004630 | phospholipase D activity(GO:0004630) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 4.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 4.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 2.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 10.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 1.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 0.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 5.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 2.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 1.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 14.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 2.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 3.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 3.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 0.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 1.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 2.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 1.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.4 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 2.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 1.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 1.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.6 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 1.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 7.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 9.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 1.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.0 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.3 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 0.7 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
0.4 | 3.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 6.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.3 | 0.3 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.3 | 3.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.3 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 12.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 2.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 2.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 0.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 5.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 1.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 0.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 0.2 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.2 | 1.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 1.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 2.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.5 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 1.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 2.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 0.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 2.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 1.2 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 1.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.1 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 1.8 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.6 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 1.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 1.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.8 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 1.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 2.3 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.1 | 2.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 1.1 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 0.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 1.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 0.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.7 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.6 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.7 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 2.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.1 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.0 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.0 | 0.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.5 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.1 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.3 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.0 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.2 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.7 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.2 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |